Our novel observations suggest that genotyping of SNPs at this locus may be useful for the study of ALS risk in a high percentage of individuals and that ATXN2 and SH2B3 variants may interact in modulating the disease pathway. This evidence concerns the gene SH2B3 and amyotrophic lateral sclerosis.